← brief for 2026-08-16 · Slowing decline

A Prospecitve Multicenter, Observational Registry Study

Trial No results yet Not peer reviewed

Key takeaways

A new study is starting in China. It will track people with chronic kidney disease to see how they are treated and how their heart and kidney health change over time. It only collects information, it does not test a new treatment. There are no results yet.

Who did this work

Run by AstraZeneca. Xiao Qiang Ding (Zhongshan Hospital Affiliated with Fudan University)
Sites: Research Site

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-08-13
https://clinicaltrials.gov/study/NCT07481526